\textit{In silico} evaluation of the potential antiarrhythmic effect of epigallocatechin-3-gallate on cardiac channelopathies

DOI10.1155/2016/7861653zbMATH Open1423.92075DBLPjournals/cmmm/BoukhabzaHAEFMA16OpenAlexW2547128052WikidataQ42233732 ScholiaQ42233732MaRDI QIDQ2011741FDOQ2011741

Authors: Maroua Boukhabza, Jaouad El Hilaly, Nourdine Attiya, Ahmed El-Haidani, Younes Filali-Zegzouti, Driss Mazouzi, Mohamed-Yassine Amarouch 

Publication date: 4 August 2017

Published in: Computational \& Mathematical Methods in Medicine (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1155/2016/7861653

Recommendations

• Defining candidate drug characteristics for Long-QT (LQT3) syndrome
• Electrophysiological effects of small conductance Ca\(^{2+}\)-activated K\(^+\) channels in atrial myocytes
• Phenomenological analysis of simple ion channel block in large populations of uncoupled cardiomyocytes
• A note on a method for determining advantageous properties of an anti-arrhythmic drug based on a mathematical model of cardiac cells
• Quantification of gastrointestinal sodium channelopathy

zbMATH Keywords

antiarrhythmic effectcardiac channelopathiesepigallocatechin-3-gallate

Mathematics Subject Classification ID

Medical applications (general) (92C50) Physiology (general) (92C30) Computational methods for problems pertaining to biology (92-08)

Cites Work

• Mathematical models of the electrical action potential of Purkinje fibre cells

Cited In (2)

• Quantification of gastrointestinal sodium channelopathy
• Defining candidate drug characteristics for Long-QT (LQT3) syndrome

This page was built for publication: \textit{In silico} evaluation of the potential antiarrhythmic effect of epigallocatechin-3-gallate on cardiac channelopathies

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2011741)